Clinical Trial Update: Pletaal SR Post Marketing Observational Study

View source ↗

Summary

Post-marketing observational study of Pletaal SR completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Pletaal SR (cilostazol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Ischemic Symptoms, Cerebral Infarction | Status: COMPLETED | Results posted: 2018-09-21